Tag: Compass Pathways - Page 6 - Psychedelic Alpha

Read more about the article Psychedelic Bulletin: Deconstructing COMPASS Pathways’ Phase 2b Results

Psychedelic Bulletin: Deconstructing COMPASS Pathways’ Phase 2b Results

Post published:November 15, 2021
Post category:Psychedelic Bulletin

Read more about the article COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021

COMPASS Pathways plc announces financial results and business highlights for the third quarter 2021

Post published:November 9, 2021
Post category:Press Release

Read more about the article COMPASS Pathways Shares Positive Topline Results from Phase 2b COMP360 Study

COMPASS Pathways Shares Positive Topline Results from Phase 2b COMP360 Study

Post published:November 9, 2021
Post category:Press Release

Read more about the article Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?

Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to be?

Post published:November 5, 2021
Post category:Analysis News

Read more about the article COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for PTSD

COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for PTSD

Post published:November 3, 2021
Post category:Press Release

Read more about the article Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups

Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups

Post published:October 20, 2021
Post category:Press Release

Read more about the article COMPASS Pathways is granted new US patent for crystalline psilocybin

COMPASS Pathways is granted new US patent for crystalline psilocybin

Post published:October 19, 2021
Post category:Press Release

Read more about the article COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs

COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs

Post published:September 14, 2021
Post category:Press Release

Read more about the article Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds

Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds

Post published:September 10, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021

COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021

Post published:August 11, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.